Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
22 March 2018
General meetings

Auditor’s report on resolution number 14 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s attestation on the remunerations paid to the five highest-paid people Open in new window

22 March 2018
General meetings

Statement of the number of voting rights – AGM 2018 Open in new window

22 March 2018
General meetings

Auditor’s report on resolutions 15-21 and 26 – 2018 General Meeting Open in new window

22 March 2018
General meetings

2017 Annual Report Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 22 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 23 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 24 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s report on resolution 25 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Third party’s report on the 2017 Company’s CSR report Open in new window

  • View previous 9 articles
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page